Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : IPHA save search
Innate Pharma Announces Its Participation to Upcoming Investor Conferences and Conference Call for First Half 2023 Business Update
Published: 2023-08-29 (Crawled : 07:00) - biospace.com/
MS | News 0 d | $90.08 1.06% -0.28% 9.5M
|
Finance
|
| O: 0.64%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 6.57%
H: 0.34%
C: -4.11%
pharma conference business update
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.18%
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: 0.06%
H: 2.34%
C: 2.29%
ALPMY | News | $9.34 -1.11% 690K
|
Manufacturing
|
| O: 0.37%
H: 0.74%
C: 0.28%
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.34%
H: 0.23%
C: -1.13%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 1.22%
H: 0.07%
C: -0.43%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.96%
H: 1.75%
C: 1.75%
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: -0.18%
H: 0.48%
C: -1.91%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
ZLAB | $13.75 -4.65% -4.87% 400K
|
Health Technology
|
| O: -1.15%
H: 1.03%
C: -1.5%
VRTX | $393.1 -0.27% -0.27% 880K
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -0.32%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: -3.1%
H: 1.2%
C: -0.8%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
BIIB | $192.13 -1.55% -1.57% 1.3M
|
Health Technology
|
| O: -3.72%
H: 0.58%
C: -3.82%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: -0.26%
H: 0.73%
C: -0.36%
ARGX | $366.37 -1.16% -1.18% 270K
|
Health Technology
|
| O: -2.3%
H: 1.65%
C: 0.83%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -1.4%
expansion growth market
Worldwide Natural Killer Cells Therapeutics Industry to 2027 - Featuring Fate Therapeutics, Fortress Biotech and Ziopharm Oncology Among Others
Published: 2022-07-01 (Crawled : 20:00) - prnewswire.com
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
| Email alert
Add to watchlist
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
| Email alert
Add to watchlist
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
biotech therapeutics
Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual Congress
Published: 2021-09-02 (Crawled : 06:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 0.58%
H: 0.36%
C: 0.29%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.13%
H: 0.28%
C: 0.0%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 44.48%
H: 7.46%
C: -20.08%
Innate Pharma to Participate in Upcoming Investor Conferences
Published: 2021-08-30 (Crawled : 05:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -1.18%
H: 1.47%
C: 0.95%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.25%
H: 0.46%
C: -0.46%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 1.42%
H: 0.0%
C: -0.28%
conference pharma
Innate Pharma to Participate in Upcoming Investor Conferences - Aug 30, 2021
Published: 2021-08-30 (Crawled : 08:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -1.18%
H: 1.47%
C: 0.95%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.25%
H: 0.46%
C: -0.46%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 1.42%
H: 0.0%
C: -0.28%
conference pharma
Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
Published: 2021-09-07 (Crawled : 06:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 1.24%
H: 0.12%
C: -0.21%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.02%
H: 0.08%
C: -0.21%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: -15.12%
H: 12.45%
C: 11.69%
conference pharma
Innate Pharma Reports First Half 2021 Financial Results and Business Update
Published: 2021-09-15 (Crawled : 06:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 1.32%
H: 0.05%
C: -0.08%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: -0.55%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 11.15%
H: 0.48%
C: -8.22%
financial results results pharma
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021
Published: 2021-09-23 (Crawled : 05:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 1.34%
H: 0.3%
C: -0.12%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.33%
H: 0.6%
C: 0.16%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 2.08%
H: 0.68%
C: -4.76%
pharma
Monalizumab Data from COAST Trial Presented at ESMO Congress 2021
Published: 2021-09-17 (Crawled : 12:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 32.17%
H: 57.24%
C: 6.58%
trial presentation
Innate Pharma 2021 Financial Calendar
Published: 2020-12-02 (Crawled : 06:00) - globenewswire.com
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: -3.82%
H: 2.46%
C: -2.46%
pharma
Innate Pharma to return US and EU Lumoxiti commercialization rights to AstraZeneca
Published: 2020-12-11 (Crawled : 06:01) - globenewswire.com
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: -19.59%
H: 6.5%
C: 1.16%
commercialization pharma
Innate Pharma to present additional efficacy data for monalizumab in combination with cetuximab in head and neck cancer at the ESMO immuno-oncology virtual congress
Published: 2020-12-03 (Crawled : 14:02) - globenewswire.com
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 7.17%
H: 1.27%
C: -3.8%
cancer
Innate Pharma to Present Additional Efficacy Data for Monalizumab in Combination With Cetuximab in Head and Neck Cancer at the ESMO Immuno-Oncology Virtual CongressPhase 2 expansion cohort data supports ongoing Phase 3 trial
Published: 2020-12-03 (Crawled : 15:00) - biospace.com/
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 7.17%
H: 1.27%
C: -3.8%
cancer phase 3 trial expansion ongoing
Innate's first NK cell engager selected by Sanofi as drug candidate for development
Published: 2021-01-05 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.33%
H: 0.66%
C: 0.31%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 4.64%
H: 0.0%
C: -1.33%
drug
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Published: 2020-12-22 (Crawled : 02:08) - prnewswire.com
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: -1.17%
H: 0.95%
C: 0.24%
Innate Pharma to participate in upcoming investor conferences
Published: 2021-01-04 (Crawled : 06:00) - globenewswire.com
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 3.42%
H: 2.36%
C: 1.89%
conference pharma
Innate Pharma advances lacutamab clinical development program
Published: 2021-02-09 (Crawled : 06:01) - globenewswire.com
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 5.18%
H: 0.0%
C: -3.9%
program pharma
Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across T-Cell Lymphomas
Published: 2021-02-03 (Crawled : 06:00) - globenewswire.com
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 2.89%
H: 3.98%
C: 3.28%
t-cell potential pharma
Number of shares and voting rights of Innate Pharma as of February 1, 2021
Published: 2021-02-24 (Crawled : 06:00) - globenewswire.com
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 5.18%
H: 0.0%
C: -2.91%
pharma
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.